The purpose of this legislation is to encourage companies to bring manufacturing operations back to the United States by providing a tax credit for investments in critical supply chain facilities. This is aimed at strengthening the domestic supply chain, particularly for essential goods like pharmaceuticals, medical devices, and semiconductors. Key provisions of this legislation include the establishment of a tax credit worth 40 percent of the qualified investments made in critical supply chain facilities.